07.01.2008 18:14:00
|
Landec Elects Nick Tompkins as Chairman of the Board of Apio and Ron Midyett Promoted to Apio CEO
Landec Corporation (Nasdaq:LNDC), today announced that Nicholas
Tompkins, a member of Landec’s Board of
Directors, has been elected as Chairman of the Board of Apio, Inc.,
Landec’s wholly-owned food technology
subsidiary. Landec also announced that Ron Midyett, a 20-year veteran in
the produce industry, has been promoted to Chief Executive Officer of
Apio, a role previously held by Mr. Tompkins.
"Ron possesses 20 years of technology and
operations experience in the produce industry with nearly three years as
Apio’s Chief Operating Officer. Ron’s
focus at Apio is on integrating technology, operations, marketing and
sales to advance and lead Apio’s future growth,”
said Nick Tompkins, Chairman of the Board of Apio.
Gary Steele, Chairman and CEO of Landec commented, "We
have a strong senior leadership team in Ron Midyett and Nick Tompkins
that will continue to profitably grow Landec’s
food business based on innovation, quality and key partner relationships.”
Ron Midyett, 42, joined Apio in May 2005 as Chief Operating Officer.
Prior to joining Apio, Mr. Midyett was Senior Vice President of
Operations for Dole Fresh Vegetables.
Nick Tompkins, as the newly elected Chairman of the Board of Apio, will
continue to focus on Apio’s strategic growth
opportunities, including new business and partner development. In
addition, Mr. Tompkins remains a valued member of Landec’s
Board of Directors.
About Apio, Inc.
Apio was founded in 1979 by Nick Tompkins and is headquartered in
Guadalupe, California. Apio, a wholly-owned subsidiary of Landec,
markets a complete line of fresh-cut vegetable products using Landec’s
proprietary BreatheWay® specialty packaging
under the Eat Smart® Brand. The proprietary
BreatheWay packaging technology provides a unique optimal atmosphere
within the package to extend the shelf life and preserve the freshness
of the produce. In addition, Apio provides its BreatheWay packaging to
strategic partners in select areas of perishable produce.
In 2004, Apio entered into an exclusive agreement with Chiquita Brands
International, Inc. to supply Chiquita with BreatheWay proprietary
banana packaging technology on a worldwide basis for the ripening,
conservation and shelf-life extension of bananas. In 2005, Apio formed
the Apio Packaging group to commercialize BreatheWay packaging solutions
with partners for additional applications.
About Landec Corporation
Landec Corporation designs, develops, manufactures and sells
temperature-activated and other specialty polymer products for a variety
of food, agricultural and licensed partner applications. The Company’s
temperature-activated polymer products are based on its patented
Intelimer® polymers which differ from other
polymers in that they can be customized to abruptly change their
physical characteristics when heated or cooled through a pre-set
temperature switch.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.
Nachrichten zu Lifecore Biomedicalmehr Nachrichten
29.11.24 |
NASDAQ Composite Index-Papier Lifecore Biomedical-Aktie: So viel Verlust hätte ein Investment in Lifecore Biomedical von vor 3 Jahren eingebracht (finanzen.at) | |
22.11.24 |
NASDAQ Composite Index-Papier Lifecore Biomedical-Aktie: So viel Verlust hätte ein Investment in Lifecore Biomedical von vor einem Jahr eingebracht (finanzen.at) | |
21.11.24 |
Gute Stimmung in New York: NASDAQ Composite zum Ende des Donnerstagshandels mit Zuschlägen (finanzen.at) | |
21.11.24 |
Freundlicher Handel: Gewinne im NASDAQ Composite (finanzen.at) | |
21.11.24 |
Anleger in New York halten sich zurück: NASDAQ Composite schwächelt mittags (finanzen.at) | |
21.11.24 |
Börse New York in Rot: NASDAQ Composite beginnt Donnerstagshandel in der Verlustzone (finanzen.at) | |
20.11.24 |
Börse New York in Rot: NASDAQ Composite präsentiert sich zum Handelsende leichter (finanzen.at) | |
20.11.24 |
Handel in New York: NASDAQ Composite verliert am Mittwochnachmittag (finanzen.at) |
Analysen zu Lifecore Biomedicalmehr Analysen
Aktien in diesem Artikel
Lifecore Biomedical | 7,00 | 0,00% |
Indizes in diesem Artikel
NASDAQ Comp. | 19 218,17 | 0,83% |